One‐year follow‐up CT findings in COVID‐19 patients: A systematic review and meta‐analysis. Issue 8 (12th June 2022)

• Record Type: Journal Article
• Authors: Watanabe, Atsuyuki; So, Matsuo; Iwagami, Masao; Fukunaga, Koichi; Takagi, Hisato; Kabata, Hiroki; Kuno, Toshiki
• Is Part Of: Respirology. Volume 27:Issue 8(2022)
• Page Start: 605
• Page End: 616
• Publication Date: 2022-06-12
• Subjects: computed tomography -- coronavirus disease -- COVID‐19 -- follow‐up -- pulmonary function test -- SARS‐CoV‐2 -- sequelae; Respiratory organs -- Diseases -- Periodicals; Respiratory organs -- Periodicals; 612.2
• DOI: 10.1111/resp.14311
• Languages: English
• ISSNs: 1323-7799

Abstract

Abstract: Coronavirus disease 2019 (COVID‐19) often causes radiological and functional pulmonary sequelae. However, evidence on 1‐year follow‐up of pulmonary sequelae is limited. We aimed to investigate the characteristics and time‐course of pulmonary sequelae after recovery from COVID‐19 through 1‐year follow‐up. We searched PubMed and EMBASE databases on 25 February 2022, and included studies with computed tomography (CT) findings at the 1‐year follow‐up. The extracted data on CT findings were analysed using a one‐group meta‐analysis. We further analysed the data in relation to COVID‐19 severity, improvement rate and lung function. Fifteen eligible studies ( N = 3134) were included. One year after COVID‐19, 32.6% (95% CI 24.0–42.6, I 2 = 92.9%) presented with residual CT abnormalities. Ground‐glass opacity and fibrotic‐like changes were frequently observed in 21.2% (95% CI 15.4–28.4, I 2 = 86.7%) and 20.6% (95% CI 11.0–35.2, I 2 = 91.9%), respectively. While the gradual recovery was seen on CT (52.9% [mid‐term] vs. 32.6% [1 year]), the frequency of CT abnormalities was higher in the severe/critical cases than in the mild/moderate cases (37.7% vs. 20.7%). In particular, fibrotic changes showed little improvement between 4–7 months and 1 year after COVID‐19. Pulmonary function tests at 1 year also showed the decline in diffusing capacity of the lung for carbon monoxide, especially in severe/critical cases. Our meta‐analysis indicated that residual CT abnormalities were common in hospitalized COVID‐19 patients 1 year after recovery, especially fibrotic changes in severe/critical cases. As these sequelae may last long, vigilant observations and longer follow‐up periods are warranted. Abstract :